Journal of general internal medicine
EBM BLS: Tirzepatide Leads to Resolution of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Without Worsening of Fibrosis.
Laura A Campbell, Stephen Fuest, Christopher D Jackson
Published: 202610.1007/s11606-025-10123-6
No abstract available for this study.